Solid Biosciences (SLDB) Share-based Compensation (2017 - 2024)
Historic Share-based Compensation for Solid Biosciences (SLDB) over the last 8 years, with Q4 2024 value amounting to $3.8 million.
- Solid Biosciences' Share-based Compensation rose 9716.2% to $3.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $10.5 million, marking a year-over-year increase of 3795.41%. This contributed to the annual value of $10.5 million for FY2024, which is 3795.41% up from last year.
- Solid Biosciences' Share-based Compensation amounted to $3.8 million in Q4 2024, which was up 9716.2% from $3.0 million recorded in Q3 2024.
- In the past 5 years, Solid Biosciences' Share-based Compensation ranged from a high of $3.8 million in Q4 2024 and a low of $1.5 million during Q3 2022
- Over the past 5 years, Solid Biosciences' median Share-based Compensation value was $2.6 million (recorded in 2020), while the average stood at $2.5 million.
- As far as peak fluctuations go, Solid Biosciences' Share-based Compensation crashed by 5538.64% in 2022, and later skyrocketed by 9716.2% in 2024.
- Over the past 5 years, Solid Biosciences' Share-based Compensation (Quarter) stood at $2.5 million in 2020, then skyrocketed by 35.62% to $3.4 million in 2021, then crashed by 53.53% to $1.6 million in 2022, then grew by 22.12% to $1.9 million in 2023, then surged by 97.16% to $3.8 million in 2024.
- Its Share-based Compensation stands at $3.8 million for Q4 2024, versus $3.0 million for Q3 2024 and $2.1 million for Q2 2024.